SCHEMBL27593155

SCHEMBL27593155

CCCN(CCC)C(=O)c1cc(C(=O)OCC)cc(C(C)Br)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 3/20 0.43
CA1 P00915 3/20 0.43
CA2 P00918 3/20 0.43
CA7 P43166 3/20 0.43
CA9 Q16790 3/20 0.43
CA14 Q9ULX7 3/20 0.43
CTSD P07339 1/20 0.42
BACE1 P56817 1/20 0.42
CYP2C19 P33261 2/20 0.38
CYP2C9 P11712 1/20 0.38
TP53 P04637 2/20 0.38
NPC1 O15118 2/20 0.38
POLB P06746 1/20 0.38
RAB9A P51151 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
MLYCD O95822 1/20 0.38
HPGD P15428 1/20 0.37
ESR1 P03372 2/20 0.36
ESR2 Q92731 1/20 0.36
EGFR P00533 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3348484 0.82 CA12 (0.44) CA12CA1CA2CA7CA9
SCHEMBL3353303 0.81 PRKCA (0.46) CA12CA1CA2CA7CA9
SCHEMBL27593153 0.80 CYP4F2 (0.42) CA12CA1CA2CA7CA9
SCHEMBL3855743 0.77 CA12 (0.42) CA12CA1CA2CA7CA9
SCHEMBL3348692 0.76 CTSD (0.43) CA12CA1CA2CA7CA9
SCHEMBL3854418 0.75 CA12 (0.51) CA12CA1CA2CA7CA9
SCHEMBL3854890 0.75 CA12 (0.51) CA12CA1CA2CA7CA9
SCHEMBL3858636 0.75 CA12 (0.42) CA12CA1CA2CA7CA9
SCHEMBL14682703 0.74 CA12 (0.58) CA12CA1CA2CA7CA9
SCHEMBL3854058 0.73 CA12 (0.43) CA12CA1CA2CA7CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100366605-C Compounds to treat alzheimer's disease ELAN PHARM INC (US) 2008-02-06 CN disclosed
CN-101090883-A Substituted hydroxyethylamines ELAN PHARM INC (US) 2007-12-19 CN disclosed
CN-1759095-A N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives ELAN PHARM INC (US) 2006-04-12 CN disclosed
CN-1447789-A Compounds for treating alzheimer's disease ELAN PHARM INC (US) 2003-10-08 CN disclosed